Santiago Torrado Durán-rekin lankidetzan egindako argitalpenak (17)

2024

  1. Topical Meloxicam Hydroxypropyl Guar Hydrogels Based on Low-Substituted Hydroxypropyl Cellulose Solid Dispersions

    Gels, Vol. 10, Núm. 3

2023

  1. Development of Chitosan/Sodium Carboxymethylcellulose Complexes to Improve the Simvastatin Release Rate: Polymer/Polymer and Drug/Polymer Interactions’ Effects on Kinetic Models

    Polymers, Vol. 15, Núm. 20

  2. Eficacia de nuevos sistemas multiparticulares deezetimiba/atorvastatina en hiperlipidemia severa

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Solid dispersions of atorvastatin with Kolliphor RH40: Enhanced supersaturation and improvement in a hyperlipidemic rat model

    International Journal of Pharmaceutics, Vol. 631

2021

  1. Estudio de diferentes proporciones de chitosán y carboximetilcelulosa para el desarrollo de complejos polielectrolíticos que logren la liberación sostenida de claritromicina en comprimidos

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 183-184

  2. Multiparticulate systems of ezetimibe micellar system and atorvastatin solid dispersion efficacy of low-dose ezetimibe/atorvastatin on high-fat diet-induced hyperlipidemia and hepatic steatosis in diabetic rats

    Pharmaceutics, Vol. 13, Núm. 3

  3. Sistemas multiparticulares de ezetimiba y atorvastatina en el tratamiento de hiperlipidemia inducida en ratas diabéticas

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 253-255

2020

  1. Improvement of the pharmacokinetic/pharmacodynamic relationship in the treatment of invasive aspergillosis with voriconazole. Reduced drug toxicity through novel rapid release formulations

    Colloids and Surfaces B: Biointerfaces, Vol. 193

2019

  1. Submicellar liquid chromatography with fluorescence detection improves the analysis of naproxen in plasma and brain tissue

    Journal of Separation Science, Vol. 42, Núm. 9, pp. 1702-1709

2014

  1. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose

    Drug Design, Development and Therapy, Vol. 8, pp. 1467-1479

2009

  1. Characterization and superficial transformations on mini-matrices made of interpolymer complexes of chitosan and carboxymethylcellulose during in vitro clarithromycin release

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 73, Núm. 1, pp. 130-139

2006

  1. Clinical trial evaluating amoxicillin and clarithromycin hydrogels (chitosan-polyacrylic acid polyionic complex) for H. pylori eradication

    Journal of Clinical Gastroenterology, Vol. 40, Núm. 7, pp. 618-622

2005

  1. Poly (acrylic acid) chitosan interpolymer complexes for stomach controlled antibiotic delivery

    Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 72, Núm. 1, pp. 191-197

2001

  1. Correlation of in vitro and in vivo acetaminophen availability from albumin microaggregates oral modified release formulations

    International Journal of Pharmaceutics, Vol. 217, Núm. 1-2, pp. 193-199

1999

  1. Quantitative determination of dimethicone in commercial tablets and capsules by Fourier transform infrared spectroscopy and antifoaming activity test

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 19, Núm. 3-4, pp. 285-292

1998

  1. Process-induced crystallite size and dissolution changes elucidated by a variety of analytical methods

    International Journal of Pharmaceutics, Vol. 166, Núm. 1, pp. 55-63

1997

  1. A novel formulation of albendazole solution: Oral bioavailability and efficacy evaluation

    International Journal of Pharmaceutics, Vol. 156, Núm. 2, pp. 181-187